US 12121541
Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted A61KA61K2039/5154A61K2039/5156
Quick answer
US patent 12121541 (Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy) held by Iovance Biotherapeutics, Inc. expires Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Iovance Biotherapeutics, Inc.
- Grant date
- Tue Oct 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 35
- CPC classes
- A61K, A61K2039/5154, A61K2039/5156, A61K2039/5158, A61K2039/55533